Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy

(2013) Ellen M. Lavoie Smith et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial

(2011) J. P. Durand et al.   ANNALS OF ONCOLOGY

Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy

(2010) Wen-Yee CHAY et al.   Asia-Pacific Journal of Clinical Oncology

The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients

(2010) N. Knijn et al.   EUROPEAN JOURNAL OF CANCER

Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study

(2010) Keiichiro Ishibashi et al.   International Journal of Clinical Oncology

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7

(2010) Axel Grothey et al.   JOURNAL OF CLINICAL ONCOLOGY

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA

(2010) Debra L. Barton et al.   SUPPORTIVE CARE IN CANCER

Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer

(2009) Toru Kono et al.   Evidence-based Complementary and Alternative Medicine

Oxaliplatin-Related Neurotoxicity: Interest of Calcium-Magnesium Infusion and No Impact on Its Efficacy

(2008) Laurence Gamelin et al.   JOURNAL OF CLINICAL ONCOLOGY